It is time to stop using topical chloramphenicol

Australian and New Zealand Journal of Ophthalmology

Volumn 25, Issue 1, 1997, Pages 83-88

  Smith, J R ^a   Wesselingh, S ^a   Coster, D J ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL;

AGED; APLASTIC ANEMIA; CONJUNCTIVITIS; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; NOTE;

EID: 0030978005     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.1997.tb01283.x     Document Type: Note

References (21)

1. Yunis AA. Chloramphenicol toxicity: 25 years of research. Am. J. Med. 1989, 87: N44-8.
2. Yunis AA, Miller AM, Salem Z, Corbett MD, Arimura GK. Nitroso-chloramphenicol: possible mediator in chloramphenicol-induced aplastic anaemia. J. Lab. Clin. Med. 1980; 96: 36-46.
3. West BC, DeVault GA, Clement JC, Williams DM. Aplastic anaemia associated with parenteral chloramphenicol: review of 10 cases including the second case of possible increased risk with cimetidine. Rev. Infect. Dis. 1988; 10: 1048-51.
4. Fraunfelder FT, Morgan RL, Yunis AA. Blood dyscrasias and topical ophthalmic chloramphenicol. Am. J. Ophthalmol. 1993; 115: 812-13.
5. Best WR. Chloramphenicol-associated blood dyscrasias: A review of cases submitted to the American Medical Association Registry. JAMA 1967; 201: 181-8.
6. Turnbridge J. Chloramphenicol for conjunctivitis (Comment). Aust. Prescriber 1996; 19: 4-5.
7. Wallerstein RO, Condit PK, Kasper CK, Brown JW, Morrison FR. Statewide study of chloramphenicol therapy and aplastic anaemia. JAMA 1969; 208: 2045-50.
8. Rosenthal RL, Blackman A. Bone-marrow hypoplasia following use of chloramphenicol eye drops. JAMA 1965; 191: 136-7.
9. Abrams SM, Degnan TJ, Vinciguerra V. Marrow aplasia following topical application of chloramphenicol ointment. Arch. Intern. Med. 1980; 140: 576-7.
10. Fraunfelder FT, Bagby GC, Kelly DJ. Fatal aplastic anaemia following topical administration of ophthalmic chloramphenicol. Am. J. Ophthalmol. 1982, 93: 356-60.
11. Issaragrisil S, Piankijagum. Aplastic anaemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature. J. Med. Assoc. Thai. 1985; 68: 309-12.
12. Besamusca FW, Bastiaensen LA. Blood dyscrasias and topically applied chloramphenicol in ophthalmology. Doc. Ophthalmol. 1986; 64: 87-95.
13. Brodsky E, Zeidan Z, Biger Y, Schneider M. Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Isr. J. Med. Sci. 1989; 25: 54.
14. De Sevilla TF, Alegre J, Vallespi T, Falco V, Martinez-Vazquez JM. Adult pure red cell aplasia following topical ocular chloramphenicol. Br. J. Ophthalmol. 1990; 74: 640.
15. McWhae JA, Chang J, Lipton JH. Drug-induced fatal aplastic anaemia following cataract surgery. Can. J. Ophthalmol. 1992; 27: 313-15.
16. International Agranulocytosis and Aplastic Anaemia Study. Incidence of aplastic anaemia: the relevance of diagnostic criteria. Blood 1987; 70: 1718-21.
17. Trope GE, Lawrence JR, Hind VMD, Bunney J. Systemic absorption of topically applied chloramphenicol eyedrops. Br. J. Ophthalmol. 1979; 63: 690-1.
18. Buckley RJK, Kirkness CM, Kanski JJ, Ridgway AEA, Tullo AB, Watson PG. Is it time to stop using chloramphenicol on 5 the eye? Safe in patients with no history of blood dyscrasia. BMJ 1995; 311: 450.
19. Hausmann K, Skrandies G. Aplastic anaemia following chloramphenicol therapy in Hamburg and surrounding districts. Postgrad. Med. J. 1974, 50 (Suppl. 5): S131-6.
20. Smick KM, Condit PK, Proctor RL, Sutcher V. Fatal aplastic anaemia: An epidemiological study of its relationship to the drug chloramphenicol. J. Chronic. Dis. 1964; 17: 899-914.
21. McGhee CNJ, Anastas CN. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia? Br. J. Ophthalmol. 1996; 80: 182-4.